Back to GILDER GAGNON HOWE & CO LLC

ARQT
Showing 8 of 9 quarters

Position history for GILDER GAGNON HOWE & CO LLC's holdings in ARCUTIS BIOTHERAPEUTICS INC

GILDER GAGNON HOWE & CO LLC holds 4.3M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $101.4M as of 2026-Q1. The position was decreased (-3.4% shares). ARQT represents 1.2% of GILDER GAGNON HOWE & CO LLC's portfolio.

Current Value

$101.4M

Current Shares

4.3M

Total Value Change

+$67.8M

Total Shares Change

+687,478

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
4.3M
-3.4%
$101.4M1.2%$23.60
0
2025-Q4
Increased
4.5M
+0.6%
$129.3M1.4%$28.08
48
2025-Q3
Increased
4.4M
+6.6%
$83.5M0.9%$18.62
45
2025-Q2
Increased
4.2M
+1.5%
$58.3M0.6%$13.74
42
2025-Q1
Increased
4.1M
+5.0%
$64.1M0.8%$15.73
44
2024-Q4
Increased
3.9M
+9.8%
$54.4M0.6%$14.20
46
2024-Q3
Decreased
3.6M
-1.7%
$33.1M0.4%$9.36
0
2024-Q2
Decreased
3.6M
-14.6%
$33.6M0.4%$9.30
0

Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used